Myo-inositol as a spectroscopic marker of neuroinflammation in frontotemporal lobar degeneration

Abstract

Background and ObjectivesCost-effective and mechanistically-informative biomarkers are needed to advance novel therapeutics for dementia. We focus on neuroinflammation in disorders associated with frontotemporal lobar degeneration (FTLD). Commonly used assays include positron emission tomography (PET) imaging and peripheral blood markers.

The paper